Etesevimab
Modify Date: 2024-04-06 13:54:34
Etesevimab structure
|
Common Name | Etesevimab | ||
|---|---|---|---|---|
| CAS Number | 2423948-94-9 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of EtesevimabEtesevimab (JS016) is a recombinant neutralizing human IgG1 anti-SARS-CoV-2 monoclonal antibody[1]. |
| Name | Etesevimab |
|---|
| Description | Etesevimab (JS016) is a recombinant neutralizing human IgG1 anti-SARS-CoV-2 monoclonal antibody[1]. |
|---|---|
| Related Catalog | |
| Target |
Kd: 6.45 nM (SARS-CoV-2 spike protein)[1] IC50: 0.32 nM (spike protein attachment to ACE2)[1] |
| In Vitro | Etesevimab (JS016) 与刺突蛋白结合的 Kd 值为 6.45 nM，阻断刺突蛋白附着在人血管紧张素转换酶 2 (ACE2) 受体的 IC50 为 0.32 nM (0.046 μg/mL)[1]。Etesevimab 阻断病毒细胞融合，防止 SARS-CoV-2 入侵人体细胞，并抑制病毒复制[1]。 |
| References |
| No Any Chemical & Physical Properties |